SCHEMBL7334635

SCHEMBL7334635

Cc1cc(C(O)CO)ccc1O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.61
TSHR P16473 4/20 0.61
TDP1 Q9NUW8 7/20 0.46
MAPT P10636 7/20 0.46
ADRB2 P07550 6/20 0.46
KDM4E B2RXH2 5/20 0.46
ADRB1 P08588 5/20 0.46
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
ADRB3 P13945 4/20 0.46
MAPK1 P28482 4/20 0.46
RECQL P46063 3/20 0.46
APEX1 P27695 3/20 0.46
ADORA3 P0DMS8 3/20 0.46
DRD2 P14416 3/20 0.46
ADRA1D P25100 3/20 0.46
ADRA1A P35348 3/20 0.46
ADRA1B P35368 3/20 0.46
MTOR P42345 3/20 0.46
HSD17B10 Q99714 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6530482 0.85 TSHR (0.45) CYP3A4TSHRTDP1MAPTADRB2
SCHEMBL13698041 0.84 CYP3A4 (0.47) CYP3A4TSHRTDP1MAPTADRB2
SCHEMBL28704040 0.83 CYP3A4 (0.50) CYP3A4TSHRTDP1MAPTADRB2
SCHEMBL7146918 0.82 BLM (0.69) CYP3A4TSHRTDP1MAPTADRB2
SCHEMBL19472347 0.82 BLM (0.69) CYP3A4TSHRTDP1MAPTADRB2
SCHEMBL29457616 0.81 MAPT (0.67) CYP3A4TSHRTDP1MAPTADRB2
SCHEMBL141609 0.81 MAPT (0.67) CYP3A4TSHRTDP1MAPTADRB2
SCHEMBL16208744 0.79 KDM4E (0.74) CYP3A4TSHRTDP1MAPTADRB2
SCHEMBL14456692 0.79 KDM4E (0.74) CYP3A4TSHRTDP1MAPTADRB2
SCHEMBL27843119 0.79 ESR1 (0.50) CYP3A4TSHRTDP1MAPTADRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110840873-A Application of docosapentaenoic acid in preparing medicine for preventing and treating schizophrenia 广东海洋大学 2020-02-28 CN disclosed
EP-0385237-B1 2-(1-piperazinyl)-4-phenylcycloalkanopyridine derivatives, processes for the production thereof, and pharmaceutical composition containing the same DAINIPPON PHARMACEUTICAL CO (JP) 1994-06-29 EP disclosed
US-5021421-A Psychotropic agents DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 1991-06-04 US disclosed